In Part 2 of our ESMO 2026 Highlights series, Dr. Stephen Liu and Dr. Narjust Florez welcome Dr. Xiao-Rong Dong, Dr. Yi-Long Wu, and Dr. Chantal Decroisette to discuss three important clinical trials: SAFFRON, SANOVO, and PERSEE. The conversations explore emerging strategies for targeting MET in EGFR-mutated non-small cell lung cancer, advances in first-line immunotherapy, and the potential implications of these findings for clinical practice. Xiao-Rong Dong, MD, PhD ([email protected]) Professor, Chief Physician and Doctoral Supervisor Director, Department of Thoracic Oncology Cancer Center of Union Hospital, Huazhong University of Science and Technology No Social Chantal Decroisette, MD Thoracic Oncologist, Medical Oncology Department Centre Léon Bérard, Lyon No Social Yi-Long Wu, MD Professor, Guangdong Lung Cancer Institute Guangdong Provincial People’s Hospital Social: @ThomasW35874311
In this Japanese-language episode of Lung Cancer Considered, Dr. Misako Nagasaka speaks with Dr. Motoko Tachihara about managing lung cancer in patients with respiratory comorbidities, including interstitial lung disease (ILD), COPD, and pulmonary infections. They discuss key considerations for treatment selection, the use of emerging therapies in patients with pre-existing lung disease, and the importance of multidisciplinary care for these complex patients. Guest Host: Misako Nagasaka, MD, PhD Associate Clinical Professor University of California, Irvine X: @MNagasaka Guest Name & Title: Motoko Tachihara, MD, PhD Associate Professor Division of Respiratory Medicine, Department of Internal Medicine Kobe University Grade School of Medicine
In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Urvi Shah and Dr. Krystle Zuniga to explore the critical role of nutrition in lung cancer care. The discussion highlights current evidence on nutrition and cancer outcomes, practical strategies to support patients during treatment and survivorship, and common misconceptions fueled by misinformation. Together, they emphasize the importance of integrating evidence-based nutrition guidance into oncology practice to improve patient well-being and quality of life. Guests: Urvi Shah, MD, MS, DipABLM Hematologist, Oncologist, and Physician Scientist Memorial Sloan Kettering Cancer Center All Social: @UrviShahMD Krystle Zuniga, PhD, RD, CSO Owner, Cancer Nutrition HQ Assistant Professor of Instruction, Department of Nutritional Sciences University of Texas Austin Social: @cancernutritionhq
LCC in Spanish: ESMO 2026 Highlights En este episodio en español de Lung Cancer Considered, la Dra. Narjust Florez conversa con la Dra. Ana Velázquez Mañana sobre los principales avances en la investigación del cáncer de pulmón presentados en ESMO 2026 en Madrid. Destacan los resultados de los estudios DeLLphi-305, SAFFRON y Krascendo 1, explorando los avances en el tratamiento del cáncer de pulmón de células pequeñas y las terapias dirigidas para el cáncer de pulmón de células no pequeñas con mutaciones de EGFR y KRAS G12C. La conversación también aborda el estudio MOIO y sus implicaciones para los intervalos de administración de la inmunoterapia, la seguridad de los tratamientos y la práctica clínica. In this Spanish-language episode of Lung Cancer Considered, host Dr. Narjust Florez welcomes Dr. Ana Velázquez Mañana to discuss key lung cancer research presented at ESMO 2026 in Madrid. They highlight findings from the DeLLphi-305, SAFFRON, and Krascendo 1 trials, exploring advances i
In this episode of Lung Cancer Considered, Drs. Jacob Sands, Ferdinandos Skoulidis, and Jarushka Naidoo discuss key research highlights from ESMO 2026, including results from the DeLLphi-305 trial evaluating tarlatamab in extensive-stage small cell lung cancer and the KRAScendo-1 trial investigating divarasib in KRAS G12C-mutated NSCLC. The discussion also explores emerging immunotherapy strategies, including findings from the MOIO and OptiTROP-Lung06 studies, advances in predicting immune-related toxicities, and the potential implications of these developments for clinical practice. Jaruska Naidoo, MD Professor of Medical Oncology Royal College of Surgeons Consultant, Medical Oncologist at Beaumont Hospital X: @DrJNaidoo Instagram: jarushkanaidoo LinkedIn: https://www.linkedin.com/in/jarushka-naidoo-127a3b97/ Jacob Sands, MD Assistant Professor of Medicine, Harvard Medical School Associate Chief, Lowe Center for Thoracic Oncology Dana-Farber Cancer Institute X: @sands_jacob Instagram: